project id: TCGA-PAAD; case submitter id: TCGA-3A-A9IH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.75; rna integrity number: 7.1; age at index: 66; days to birth: -24174; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24174; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1021.0; icd 10 code: C25.1; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of pancreas; synchronous malignancy: No; tissue or organ of origin: Body of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 686; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-3A-A9IH-01A-01; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 50.0;